59 results
424B5
CRVS
Corvus Pharmaceuticals, Inc.
3 May 24
Prospectus supplement for primary offering
4:05pm
) on any gain realized upon the sale or other taxable disposition of the Securities, which may be offset by certain U.S. source capital losses of the non
8-K
EX-99.1
7vbpau0kcuuhovvv0u
3 Nov 22
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
jfbwxnunmrilh02
2 Aug 21
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
vwokoznnb56urzz
29 Apr 21
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
4:08pm